EFIB, the European Forum for Industrial Biotechnology and Bioeconomy, which travels to Europe’s major cities every year, will take place for the 15th time in October next year in Vilnius, the capital of Lithuania. This was announced by the organiser EuropaBio, the European Association of Biotechnology Industries, at an event in Vienna. “I am glad …

by Francesco Condello

At the beginning of 1971, the first enzyme factory opened in Vilnius. Out of five being built in the USSR territory at that time, it was the first one to start its operations. A research centre was opened in this factory in the summer same year. This factory gave the biotechnology sector in Lithuania a …

by Francesco Condello

Lithuania is becoming a growth hotspot for digital health as the Life Sciences sector here is regarded as one of the most highly developed in Central and Eastern Europe. Life Sciences is high on the political agenda and digital health sector therefore is boosted by an integrated network of science valleys and universities that supply …

by Francesco Condello

Last year, Lithuania’s biotechnology sector grew by almost 87%. Businesses in the sector generated revenues of close to €2 billion and contributed around 2.5% to the country’s GDP. One employee of the sector generated 780,000 euros in revenue in 2020 and 500,000 euros in 2019. Overall, the revenues of Lithuania’s biotech sector have increased nine …

by Francesco Condello

Last month, the Lithuanian Health Technology Ecosystem welcomed two new industry members – ’Ligence’, ’Imunodiagnostika’ –  and one academic member– ’Biobank at Vilnius University Hospital Santaros Klinikos’ – to its community. These three organisations aim to contribute significantly to the global pandemic response by developing novel products and technologies. The revenues of Lithuania’s biotech sector …

by Francesco Condello

Droplet Genomics, a Lithuanian biotech startup, has today announced that it has raised a total of €1M in a Seed funding round led by Practica Capital, with contribution from Angel investors. Droplet Genomics is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology. Owing to its unparalleled throughput, droplet microfluidics enables researchers to …

by Francesco Condello

In order to attract more investment in research, experimental development and innovation (R & D & I), the Ministry of Economy and Innovation is proposing to set up an Innovation Promotion Fund. This fund would ensure efficient financing of R & D & I activities and contribute to their development. The fund would also make …

by Heather Smith

Rūta Laukien, a Lithuania-born US businesswoman is establishing a fund that will invest in biotechnology companies and start-ups in the Baltic States. The company is registered in Luxembourg, however, its headquarters will be based in Lithuania. The fund will manage about EUR 40–50 million, Lithuanian business daily Verslo žinios reports. Ms Laukien says that the newly established GrayBella Capital …

by Heather Smith

The year of 2020 was different for all of us. The global pandemic affected wide range of industries: biotechnology and natural sciences sectors were no exception. Despite the unusual circumstances this period has served biotechnology industry many opportunities and enabled effective contribution in the global response to the COVID pandemic. Lithuanian biotechnology sector is no …

by Heather Smith

Center for Innovative Medicine (Vilnius) joined Lithuanian Health technology Ecosystem to support scientific innovation transfer into clinically relevant knowledge and expertise. Center for Innovative Medicine is an advanced and competitive biomedical research center operating as an open access facility with a focus on healthcare innovations, specifically stem cells and recombinant molecules technologies for tissue engineering and …

by Heather Smith
EnglishFrenchItalianPortugueseSpanish